Treatments and Specialities

ITRT develops advanced therapy medicinal products with Cultured Mesenchymal Cells (CMC), manufactured under GMP standards and individually authorized by the AEMPS.

Clinical trials have demonstrated safety and structural efficacy in musculoskeletal conditions such as osteoarthritis, tendinopathies, and nonunion fractures.

These products require a medical prescription and individual authorization from the AEMPS. This information is for educational purposes only and does not replace medical advice.

como-se-puede-curar-la-tendinopatiaTendon injuries
CMC administered intratendinously has demonstrated structural regeneration in the patellar, Achilles, hamstring, and supraspinatus tendons, validated by MRI and associated with sustained functional improvement.
terapida-celular-avanzada-para-la-discopatia-lumbarIntervertebral disc injuries
In lumbar disc degeneration, intradiscal administration of CMC has shown structural recovery on MRI and sustained pain reduction, with extended clinical follow-up.
antes-y-despues-de-una-artrosis-con-terapia-celular-avanzadaCartilage injuries
ITRT has evaluated CMC in osteoarthritis of the knee, hip, shoulder, and other peripheral joints, whether degenerative or post-traumatic, with clinical evidence of cartilage regeneration and functional improvement.

Treatments and Specialities

Subscribe to our Newsletter